Skip to main content
Erschienen in:

01.06.2019 | Original Article

Relevance of TSH evaluation in elderly in-patients with non-thyroidal illness

verfasst von: J. Rosenfarb, N. Sforza, R. Rujelman, Y. Morosan Allo, C. Parisi, E. Blanc, C. Frigerio, P. Fossati, D. Caruso, C. Faingold, T. Meroño, G. Brenta

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Non-thyroidal illness (NTI) is frequent in hospitalized patients. Its recovery is characterized by a raise in TSH levels. However, the clinical significance of high TSH levels at admission in hospitalized elderly patients with NTI remains uncertain.

Aim

To explore the relevance of baseline TSH evaluation in hospitalized elderly patients with NTI.

Methods

We examined the participants with NTI (n = 123) from our previous study (Sforza, 2017). NTI was defined as: low T3 (< 80 ng/dL) and normal or low total T4 in the presence of TSH values between 0.1 and 6.0 mU/L. Thyroid function tests were performed on day 1 and day 8 of the hospital stay. Positive TSH changes (+ ΔTSH) were considered when the day-8 TSH value increased more than the reference change value for TSH (+ 78%). Multiple logistic regression was used to evaluate the independent association of baseline TSH, sex, clinical comorbidities (by ACE-27) and medications with + ΔTSH.

Results

Out of 123 patients (77 ± 8 years, 52% female), 34 showed a + ΔTSH. These patients had a lower TSH at admission (p < 0.001) and intra-hospital mortality (p = 0.003) than the others. In multiple logistic regression, TSH > 2.11 mU/L at baseline was associated with reduced odds to show + ΔTSH [odds ratio (95 CI) 0.29 (0.11–0.75); p = 0.011] in a model adjusted by age, sex and ACE-27.

Discussion

Inappropriately higher TSH levels at admission in hospitalized elderly patients were associated with a reduced ability to raise their TSH levels later on. The present results confront the idea that TSH levels at admission are irrelevant in this clinical context.
Literatur
1.
Zurück zum Zitat Van den Berghe G, De Zegher F, Bouillon R (1998) Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83(6):1827–1834PubMed Van den Berghe G, De Zegher F, Bouillon R (1998) Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 83(6):1827–1834PubMed
2.
Zurück zum Zitat Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev 3(2):164–217CrossRef Wartofsky L, Burman KD (1982) Alterations in thyroid function in patients with systemic illness: the “euthyroid sick syndrome”. Endocr Rev 3(2):164–217CrossRef
3.
Zurück zum Zitat Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23(1):38–89CrossRef Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR (2002) Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23(1):38–89CrossRef
4.
Zurück zum Zitat Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23(1):78–83CrossRef Rothwell PM, Lawler PG (1995) Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 23(1):78–83CrossRef
5.
Zurück zum Zitat Docter R, Krenning E, Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 39(5):499–518CrossRef Docter R, Krenning E, Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol 39(5):499–518CrossRef
7.
Zurück zum Zitat Mingote E, Meroño T, Rujelman R, Marquez A, Fossati P, Gurfinkiel M, Schnitman M, Brites F, Faingold C, Brenta G (2012) High TSH and low T4 as prognostic markers in older patients. HORMONES 11(3):350–355CrossRef Mingote E, Meroño T, Rujelman R, Marquez A, Fossati P, Gurfinkiel M, Schnitman M, Brites F, Faingold C, Brenta G (2012) High TSH and low T4 as prognostic markers in older patients. HORMONES 11(3):350–355CrossRef
10.
Zurück zum Zitat McIver B, Gorman C (1997) Euthyroid sick syndrome: an overview. Thyroid 7(1):125–132CrossRef McIver B, Gorman C (1997) Euthyroid sick syndrome: an overview. Thyroid 7(1):125–132CrossRef
13.
Zurück zum Zitat Maldonado LS, Murata GH, Hershman JM, Braunstein GD (1992) Do thyroid function tests independently predict survival in the critically ill? Thyroid 2(2):119–123CrossRef Maldonado LS, Murata GH, Hershman JM, Braunstein GD (1992) Do thyroid function tests independently predict survival in the critically ill? Thyroid 2(2):119–123CrossRef
16.
Zurück zum Zitat Delpont B, Aboa-Eboule C, Durier J, Petit JM, Daumas A, Legris N, Daubail B, Giroud M, Bejot Y (2016) Associations between thyroid stimulating hormone levels and both severity and early outcome of patients with ischemic stroke. Eur Neurol 76(3–4):125–131. https://doi.org/10.1159/000449055 CrossRefPubMed Delpont B, Aboa-Eboule C, Durier J, Petit JM, Daumas A, Legris N, Daubail B, Giroud M, Bejot Y (2016) Associations between thyroid stimulating hormone levels and both severity and early outcome of patients with ischemic stroke. Eur Neurol 76(3–4):125–131. https://​doi.​org/​10.​1159/​000449055 CrossRefPubMed
17.
Zurück zum Zitat Kaptein EM, LoPresti JS, Kaptein MJ (2014) Is an isolated TSH elevation in chronic nonthyroidal illness “subclinical hypothyroidism”? J Clin Endocrinol Metab 99(11):4015–4026CrossRef Kaptein EM, LoPresti JS, Kaptein MJ (2014) Is an isolated TSH elevation in chronic nonthyroidal illness “subclinical hypothyroidism”? J Clin Endocrinol Metab 99(11):4015–4026CrossRef
18.
Zurück zum Zitat Spencer C, Elgen A, Shen D, Duds M, Quails S, Weiss S, Nicoloft J (1987) specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33(8):1391–1396PubMed Spencer C, Elgen A, Shen D, Duds M, Quails S, Weiss S, Nicoloft J (1987) specificity of sensitive assays of thyrotropin (TSH) used to screen for thyroid disease in hospitalized patients. Clin Chem 33(8):1391–1396PubMed
20.
Zurück zum Zitat Fraser CG (2001) Biological variation: from principles to practice. American Association of Clinical Chemistry, Washington Fraser CG (2001) Biological variation: from principles to practice. American Association of Clinical Chemistry, Washington
23.
Zurück zum Zitat Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82(12):4032–4036PubMed Fliers E, Guldenaar SE, Wiersinga WM, Swaab DF (1997) Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. J Clin Endocrinol Metab 82(12):4032–4036PubMed
25.
Zurück zum Zitat Juarez-Cedillo T, Basurto-Acevedo L, Vega-Garcia S, Sanchez-Rodriguez Martha A, Retana-Ugalde R, Juarez-Cedillo E, Gonzalez-Melendez Roberto C, Escobedo-de-la-Pena J (2017) Prevalence of thyroid dysfunction and its impact on cognition in older mexican adults: (SADEM study). J Endocrinol Investig 40(9):945–952. https://doi.org/10.1007/s40618-017-0654-6 CrossRef Juarez-Cedillo T, Basurto-Acevedo L, Vega-Garcia S, Sanchez-Rodriguez Martha A, Retana-Ugalde R, Juarez-Cedillo E, Gonzalez-Melendez Roberto C, Escobedo-de-la-Pena J (2017) Prevalence of thyroid dysfunction and its impact on cognition in older mexican adults: (SADEM study). J Endocrinol Investig 40(9):945–952. https://​doi.​org/​10.​1007/​s40618-017-0654-6 CrossRef
27.
Zurück zum Zitat Peeters RP, Wouters PJ, Van Toor H, Kaptein E, Visser TJ, Van den Berghe G (2005) Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90(8):4559–4565. https://doi.org/10.1210/jc.2005-0535 CrossRefPubMed Peeters RP, Wouters PJ, Van Toor H, Kaptein E, Visser TJ, Van den Berghe G (2005) Serum 3,3′,5′-triiodothyronine (rT3) and 3,5,3′-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 90(8):4559–4565. https://​doi.​org/​10.​1210/​jc.​2005-0535 CrossRefPubMed
Metadaten
Titel
Relevance of TSH evaluation in elderly in-patients with non-thyroidal illness
verfasst von
J. Rosenfarb
N. Sforza
R. Rujelman
Y. Morosan Allo
C. Parisi
E. Blanc
C. Frigerio
P. Fossati
D. Caruso
C. Faingold
T. Meroño
G. Brenta
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Endocrinological Investigation / Ausgabe 6/2019
Elektronische ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-018-0967-0

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

CDK4/6-Inhibitoren bei Brustkrebs in die Zweitlinie aufschieben?

Ergebnisse einer Phase-III-Studie sprechen dafür, dass die Behandlung mit CDK4/6-Inhibitoren bei fortgeschrittenem HR-positivem, HER2-negativem Brustkrebs auch auf die Zweitlinie verschoben werden könnte, ohne die onkologischen Ergebnisse zu kompromittieren.

Inhalative Steroide bei COPD nicht kardioprotektiv

  • 10.01.2025
  • COPD
  • Nachrichten

Ob inhalative Kortikosteroide (ICS) COPD-Kranke außer vor akuten Exazerbationen auch vor kardiovaskulären Komplikationen schützen können, ist unklar. Eine bevölkerungsbasierte Studie aus England spricht nicht dafür.

Kaffeegenuss sicher bei Vorhofflimmern

Menschen mit Vorhofflimmern fürchten oft, Kaffee könnte schlecht für ihr Herz sein. Solche Ängste sind offenbar unbegründet: Zwei Schweizer Untersuchungen deuten sogar auf eine reduzierte Rate von kardiovaskulären Ereignissen unter Kaffeetrinkern.

Cannabisextrakt verbessert Antiemese bei Chemotherapie

Sprechen Krebskranke auf die übliche Antiemese während einer Chemotherapie nicht ausreichend an, lohnt sich möglicherweise eine Behandlung mit Cannabisextrakt. In einer Phase-2/3-Studie ließ sich die antiemetische Response mit einem solchen Extrakt erheblich verbessern.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.